Heart Rhythm problem National Conference in Delhi on Third September

  • News
  • August 15, 2017

NEW-DELHI: A national level conference on issue of Heart Rhythm problems will be held in national capital New-Delhi on third september at Hotel Grand Vasant.Dr Rohit Walia organiser of the conference told that.

Heart rhythm problems are common and untreated  may lead to life threatening conditions.Atrial Fibrillation( irregular fast rhythm from upper part of heart) is most common heart rhythm disorder and responsible for stroke commonly known as brain attack or paralysis. Similarly ventricular( lower chamber of heart)  rhythm problems are responsible for sudden cardiac arrest ( sudden stoppage of heart in previously apparently normal person) which is leading cause of death.

Presently heart rhythm problem specialist are very few in India and most of even tertiary centres lack specialist to perform specialised procedures to cure these disorders. In order to spread awareness and educate masses first such conference is being organised.

  • Related Posts

    • News
    • May 27, 2025
    • 212 views
    Ramping Up Community for JeevanRaksha during Disasters

    CBDM India 2025 will Champion Health Resilience and Local Response Bengaluru: As India and its neighbours continue to confront the double threat of increasing natural disasters and unpredictable man-made crises—including…

    • News
    • February 1, 2025
    • 324 views
    Union Budget 2025 pleased Healthcare Leaders except for a Letdown or two

    New Delhi: Healthcare leaders expressed overall satisfaction over Union Budget 2025 except for a letdown or two. Rajiv Nath, Forum Coordinator, Association of Indian Medical Device Industry (AiMeD), though appreciated…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Pharma stock jumps after receiving approval from UK’s MHRA to sell new pharma product

    Pharma stock jumps after receiving approval from UK’s MHRA to sell new pharma product

    HIV prevention drug hailed as a ‘breakthrough’ gets FDA approval

    HIV prevention drug hailed as a ‘breakthrough’ gets FDA approval

    ED raids three pharma units in Baddi, Nalagarh

    ED raids three pharma units in Baddi, Nalagarh

    Glenmark Pharma: FDA concludes inspection at US facility, issues five observations

    Glenmark Pharma: FDA concludes inspection at US facility, issues five observations